KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Teladoc Health (TDOC) over the last 13 years, with Q3 2025 value amounting to $176.9 million.

  • Teladoc Health's Shares Outstanding (Weighted Average) rose 317.12% to $176.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $176.9 million, marking a year-over-year increase of 317.12%. This contributed to the annual value of $170.6 million for FY2024, which is 363.71% up from last year.
  • Latest data reveals that Teladoc Health reported Shares Outstanding (Weighted Average) of $176.9 million as of Q3 2025, which was up 317.12% from $175.9 million recorded in Q2 2025.
  • Over the past 5 years, Teladoc Health's Shares Outstanding (Weighted Average) peaked at $176.9 million during Q3 2025, and registered a low of $152.2 million during Q1 2021.
  • In the last 5 years, Teladoc Health's Shares Outstanding (Weighted Average) had a median value of $164.2 million in 2023 and averaged $164.9 million.
  • As far as peak fluctuations go, Teladoc Health's Shares Outstanding (Weighted Average) skyrocketed by 10765.55% in 2021, and later soared by 143.81% in 2022.
  • Over the past 5 years, Teladoc Health's Shares Outstanding (Weighted Average) (Quarter) stood at $156.9 million in 2021, then increased by 2.88% to $161.5 million in 2022, then rose by 1.93% to $164.6 million in 2023, then grew by 3.64% to $170.6 million in 2024, then increased by 3.74% to $176.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $176.9 million for Q3 2025, versus $175.9 million for Q2 2025 and $174.2 million for Q1 2025.